Brandywine reported FFO of $0.11 per share for Q1 2026, aligning with consensus and management guidance. The company has $36 million cash on hand and only $65 million drawn on its credit line, highlighting a solid liquidity base. This low leverage position provides flexibility for strategic initiatives such as asset sales or share repurchases.

The wholly owned core portfolio is 88.3% occupied and 89.9% leased, with expectations of positive net absorption for the first time in several years. Uptown ATX’s 902 building has attracted interest primarily from existing tenants seeking significant expansions, prompting readiness for renovation projects. The Philadelphia life sciences segment is showing improved capital flow and active tenant dialogues, driven by tight Class A office supply.

Management noted strong investor demand across institutional and private capital segments for both core and non-core assets. Proceeds from planned asset dispositions will be directed toward debt reduction and liquidity enhancement, while maintaining the option for leverage-neutral share buybacks if pricing and sales velocity are favorable. This strategy aims to bolster credit metrics and optimize the long-term portfolio mix.